Rentschler strengthens Japanese ties with Summit Pharmaceuticals | Healthcare Asia Magazine
, Japan

Rentschler strengthens Japanese ties with Summit Pharmaceuticals

The East Asian country is the world’s third largest pharmaceuticals market.

German pharmaceutical CDMO Rentschler will acquire new contracts in Japan through the enhancement of its partnership with Sumitomo subsidiary Summit Pharmaceuticals, according to a press release.

Japan is the world’s third largest pharmaceuticals market with a growth forecast of US$89 to $93b by 2023, the press release stated. An increase in biopharmaceutical startups has contributed to the growth in the industry.

Through this venture, Rentschler will give a presentation at BioJapan 2019, a biotechnology summit, on October 9-11 in Yokohama.
 

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!